Aeglea Bio Therapeutics Inc (AGLE)

NASDAQ
0.440
-0.031(-6.57%)
  • Volume:
    1,078,506
  • Day's Range:
    0.420 - 0.470
  • 52 wk Range:
    0.372 - 4.830

AGLE Overview

Prev. Close
0.471
Day's Range
0.42-0.47
Revenue
6.57M
Open
0.47
52 wk Range
0.372-4.83
EPS
-1.11
Volume
1,078,506
Market Cap
27.06M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,820,851
P/E Ratio
-1.39
Beta
1.91
1-Year Change
-92.16%
Shares Outstanding
61,511,078
Next Earnings Date
Mar 15, 2023
What is your sentiment on Aeglea Bio Therapeutics?
or
Vote to see community's results!

Aeglea Bio Therapeutics Inc News

Aeglea Bio Therapeutics Inc Analysis

Aeglea Bio Therapeutics Inc Company Profile

Aeglea Bio Therapeutics Inc Company Profile

Employees
92

Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company’s lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. It also develops AGLE-177, a polyethylene glycol modified, which is in Phase I/II clinical trial for the treatment of patient with homocystinuria. In addition, the company’s preclinical pipeline includes AGLE-325 for the treatment of cystinuria, as well as other research programs. The company was formerly known as Aeglea BioTherapeutics Holdings, LLC and changed its name to Aeglea BioTherapeutics, Inc. in March 2015. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas.

Read More

Analyst Price Target

Average2.700 (+517.85% Upside)
High6
Low1
Price0.437
No. of Analysts5
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Sell
SummaryNeutralNeutralStrong SellStrong SellStrong Sell
  • Sidus Space Signs MOU with Exo-Space to Support Edge Computing Technology
    0
    • to the moon
      0